Administration of a long-acting antipsychotic injection to a child while managing contraindicated polypharmacy interactions and transition between services.

Autor: Akram, Gazala, Mitchell, Fiona
Zdroj: BMJ Case Reports; 6/14/2019, Vol. 12 Issue 6, p1-3, 3p
Abstrakt: Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using secondgeneration long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index